Skip to main content

Animations

MJFF Publications

3121 - 3130 of 6451 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/psp4.13112
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Normative vs. patient-specific brain connectivity in deep brain stimulation
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2020.117307
    Citation Count: 133
  • Summary Details
    OPEN
    Title: GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29773
    Citation Count: 2
  • Summary Details
    OPEN
    Title: PINK1 is a target of T cell responses in Parkinson’s disease
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci180478
    Citation Count: 20
  • Summary Details
    OPEN
    Title: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00779-9
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00626-6
    Citation Count: 16
  • Summary Details
    OPEN
    Title: ePresentations
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.16338
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00504-1
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.13357
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.